Botswana is investigating the death of two patients after being vaccinated against the coronavirus with AstraZeneca, the country's health ministry reported.

According to RIA Novosti, both deceased are elderly people.

The health ministry has instructed the country's medical regulator to investigate the cause of their death.

Since the end of March, Botswana has been vaccinating with AstraZeneca, manufactured in India. To date, more than 31,000 people have received the vaccine. FROM

A number of European countries have temporarily suspended vaccination with the British-Swedish company AstraZeneca due to a series of reports of possible thromboembolic complications in those vaccinated. The first reports came from Austria, where one patient died ten days after vaccination and another was urgently hospitalized with pulmonary embolism.

In turn, the World Health Organization announced the need to continue vaccination with AstraZeneca, noting that venous thromboembolism is one of the most common cardiovascular diseases in the world.